Kyntra Bio Inc.
KYNB | NASDAQ
$4.58
+$0.01 (+0.22%)
Nov 2, 2026, 11:24 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4.62M | 7.44M | 6.44M | -118.09M | -72.84M | -73.19M | -50.56M | 99.83M | 93.63M | 136.96M | 147.75M | 154.98M | 130.58M | 116.07M | 140.74M | 122.91M | 263.15M | 257.71M | 235.31M | 283.77M | 171.82M | 190.35M |
Cost of Revenue | 3.78M | 4.08M | 556K | -19.65M | -14.49M | 17.71M | 74.96M | 101.03M | 99.98M | 73.19M | 18.85M | 18.37M | 18.43M | 19.53M | 109.3M | 110.08M | 184.92M | 303.76M | 288.58M | 285.48M | 208.55M | 85.98M |
Gross Profit | 838K | 3.36M | 5.88M | -98.45M | -58.35M | -90.89M | -125.52M | -1.2M | -6.35M | 63.77M | 128.9M | 136.61M | 112.15M | 96.54M | 31.44M | 12.83M | 78.23M | -46.05M | -53.27M | -1.72M | -36.72M | 104.37M |
Operating Income | -50.83M | -44.92M | -45.9M | -123.48M | -134.89M | -169.64M | -204.02M | -166.56M | -213.27M | -254.91M | -281.82M | -293.77M | -323.95M | -314.12M | -301.03M | -370.12M | -225.48M | -281.1M | -288.53M | -211.29M | -229.93M | -181.23M |
Interest Income | 4.99M | 5.27M | 4.57M | 1.83M | 4.71M | 5.32M | 7.14M | 9.43M | 9.93M | 11.68M | 10.48M | 8.91M | 6.41M | 8.96M | 7.92M | 8.04M | 6.24M | 1.04M | 1.04M | 274K | 1.76M | 2.4M |
Pretax Income | -30.91M | -56.66M | -58.29M | -131.27M | -135.2M | -168.8M | -201.08M | -169.64M | -216.1M | -256.64M | -284.23M | -294.14M | -322.15M | -306.84M | -293.3M | -361.2M | -219.76M | -281.15M | -289.68M | -214.17M | -230.86M | -182.01M |
Net Income | 183.19M | 163.62M | 183.45M | 163.49M | -2.07M | -10.01M | -47.58M | -121.79M | -168.32M | -240.46M | -284.23M | -294.18M | -322.21M | -307.15M | -293.65M | -361.56M | -220.11M | -281.47M | -290.02M | -214.58M | -231.37M | -182.7M |
Selling & General & Admin | 28.22M | 25.79M | 27.71M | 6.4M | 18.85M | 12.01M | 4.23M | 41.78M | 49.8M | 80.98M | 115.25M | 125M | 129.32M | 128.4M | 94.13M | 92.32M | 62.41M | 32.16M | 32.16M | 42.25M | -6.73M | 56.8M |
Research & Development | 22.86M | 21.91M | 23.52M | 17.74M | 38.23M | 64.73M | 92.04M | 142.26M | 181.75M | 244.86M | 282.86M | 292.79M | 306.77M | 282.26M | 296.79M | 349.08M | 349.78M | 401.39M | 387.04M | 351.26M | 333.85M | 272.7M |
Other Expenses | 586K | 575K | 553K | 900K | 19.45M | 2M | -17.78M | -18.68M | -24.62M | -7.17M | 12.61M | 12.61M | n/a | n/a | -58.45M | -58.45M | -108.48M | -198.49M | -183.94M | -183.94M | -133.91M | -43.9M |
Operating Expenses | 51.67M | 48.28M | 51.78M | 25.03M | 76.54M | 78.74M | 78.5M | 165.36M | 206.92M | 318.67M | 410.72M | 430.39M | 436.1M | 410.66M | 332.46M | 382.95M | 303.71M | 235.05M | 235.26M | 209.57M | 193.21M | 285.6M |
Interest Expense | 9.29M | 8.93M | 8.76M | 6.35M | 9.26M | 9.12M | 8.95M | 14.02M | 14.05M | 15.25M | 15.53M | 11.58M | 6.64M | 3.72M | 1.76M | 754K | 2.08M | 2.66M | 2.74M | 3.17M | 2.34M | 2.27M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 55.45M | 52.36M | 52.34M | 5.39M | 62.05M | 96.45M | 153.46M | 266.4M | 306.9M | 391.86M | 429.57M | 448.75M | 454.53M | 430.19M | 441.76M | 493.03M | 488.63M | 538.8M | 523.84M | 495.05M | 401.75M | 371.58M |
Income Tax Expense | -1K | -92K | -90K | -142K | -130K | -319K | -314K | -182K | -110K | -64K | 3K | 31K | 61K | 319K | 358K | 362K | 354K | 328K | 349K | 407K | 516K | 688K |
Shares Outstanding (Basic) | 4.05M | 4.05M | 4.04M | 4.04M | 4.04M | 4.04M | 4.03M | 4.02M | 3.99M | 3.96M | 3.94M | 3.93M | 3.91M | 3.79M | 3.76M | 3.75M | 3.74M | 3.72M | 3.71M | 3.71M | 3.69M | 3.67M |
Shares Outstanding (Diluted) | 4.05M | 4.05M | 4.04M | 4.04M | 4.04M | 4.04M | 4.03M | 4.02M | 3.99M | 3.96M | 3.94M | 3.93M | 3.91M | 3.79M | 3.76M | 3.75M | 3.74M | 3.72M | 3.71M | 3.71M | 3.69M | 3.67M |
EPS (Basic) | 58.19 | 53.35 | 57.16 | 52.28 | -1.58 | -3.59 | -3.97 | -9.04 | -5.44 | -2.45 | -2.93 | -3.06 | -3.39 | -3.27 | -3.14 | -3.89 | -2.37 | -3.04 | -3.14 | -2.33 | -2.51 | -2.01 |
EPS (Diluted) | 58.19 | 53.35 | 57.16 | 52.28 | -1.58 | -3.59 | -3.97 | -9.04 | -5.44 | -2.45 | -2.93 | -3.06 | -3.39 | -3.27 | -3.14 | -3.89 | -2.37 | -3.04 | -3.14 | -2.33 | -2.52 | -2.02 |
EBITDA | -94.01M | -56.06M | -57.55M | -127.7M | -129.06M | -162.24M | -194.19M | -152.92M | -197.49M | -235.44M | -261.41M | -274.12M | -306.49M | -294.18M | -282.18M | -351.26M | -208.17M | -266.77M | -272.23M | -193.05M | -207.57M | -157.56M |
EBIT | -94.22M | -56.49M | -58.29M | -128.79M | -130.7M | -164.44M | -196.88M | -157.13M | -203.34M | -243.23M | -271.34M | -284.87M | -317.54M | -305.17M | -292.79M | -361.76M | -218.58M | -278.83M | -287.04M | -210.76M | -228.27M | -179.49M |
Depreciation & Amortization | 207K | 428K | 748K | 1.09M | 1.64M | 2.2M | 2.69M | 4.22M | 5.85M | 7.79M | 9.93M | 10.75M | 11.05M | 10.99M | 10.6M | 10.5M | 10.41M | 12.05M | 14.81M | 17.72M | 20.7M | 21.92M |
Add to Watchlist
Select watchlists to add or remove KYNB